Skip to Content
BiomedicinesBiomedicines
  • Comment
  • Open Access

29 May 2026

2 Pages

Comment on Spedicati et al. Hidden in the Genome: The First Italian Family with North Carolina Macular Dystrophy Carrying a Novel PRDM13 and CCNC Duplication. Biomedicines 2025, 13, 1904

Macula and Retina Institute, 411 N. Central Ave Ste 115, Glendale, CA 91203, USA
We read the article by Spedicati et al., “Hidden in the Genome: The First Italian Family with North Carolina Macular Dystrophy Carrying a Novel PRDM13 and CCNC Duplication,” with great interest [1]. The authors describe a novel 98 kb duplication involving PRDM13 and CCNC associated with North Carolina macular dystrophy (NCMD), identified as the first Italian family diagnosed with NCMD. Their work expands the NCMD spectrum of mutations and family ancestry.
We would like to draw attention to an earlier report by Manes et al., which describes a family with NCMD carrying a PRDM13-related duplication identified through whole-genome sequencing [2]. Although that pedigree was described in the article as a French family in Grenoble, France, the family’s origins were from Northern Italy. However, Manes et al. failed to mention the Italian heritage in their publication and there was no possible way for Spedicati et al. to be aware of this. We knew of this family’s Italian heritage because we had ascertained this exact same family in Grenoble, France, in 1996. The family history was personally and directly ascertained by KWS from the family members, which was also consistent with their Italian surname. Although Manes et al. ascertained the family after us, they identified the mutation before we did.
We emphasize that this observation does not diminish the novelty of the PRDM13 and CCNC duplication reported by Spedicati et al. To avoid possible misinterpretation in future citations, the statement might be more precisely phrased as “the first NCMD family ascertained in Italy carrying a novel PRDM13 and CCNC duplication” or similar language that distinguishes between ancestry and country of examination. In the literature, there are now two Italian families with NCMD.
Thank you for the opportunity to contribute this clarification to the NCMD literature.

Conflicts of Interest

Kent W. Small, US Patent No 10 973 855 B2. The authors declare no conflict of interest.

References

  1. Spedicati, B.; Pasquetti, D.; Santin, A.; Zampieri, S.; Morgan, A.; Lenarduzzi, S.; Nardone, G.G.; Paccagnella, E.; Cappellani, S.; Diplotti, L.; et al. Hidden in the Genome: The First Italian Family with North Carolina Macular Dystrophy Carrying a Novel PRDM13 and CCNC Duplication. Biomedicines 2025, 13, 1904. [Google Scholar] [CrossRef] [Scilit]
  2. Manes, G.; Joly, W.; Guignard, T.; Smirnov, V.; Berthemy, S.; Bocquet, B.; Audo, I.; Zeitz, C.; Sahel, J.; Cazevieille, C.; et al. A novel duplication of PRDM13 causes North Carolina macular dystrophy: Overexpression of PRDM13 orthologue in Drosophila eye reproduces the human phenotype. Hum. Mol. Genet. 2017, 26, 4367–4374. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.